Streetbeat News

Products Services

ARQT

Arcutis Biotherapeutics' stock is trading higher following the FDA's approval of its Zoryve topical foam for seborrheic dermatitis in individuals aged nine and older.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 3:12 pm

BALL

Ball Aerospace has been selected by NASA to conduct a Phase A study for the ECCCO mission, aimed at understanding the sun's coronal structure. The mission will use advanced imaging and spectroscopy to observe the middle corona, a largely unexplored region. Ball Aerospace will design and build the spacecraft, while the Smithsonian Astrophysical Observatory (SAO) will design the imager and spectrometers and lead science planning. Ball Aerospace is also conducting a study for the CMEx mission under NASA's SMEX program.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 3:02 pm

MSI

Motorola Solutions (NYSE:MSI) has acquired IPVideo, the creator of the HALO Smart Sensor, a multifunctional safety and security device. The HALO Smart Sensor is designed for areas where traditional video security is not suitable and can detect various health and safety threats. The terms of the transaction were not disclosed. This acquisition aligns with Motorola Solutions' strategy to enhance its physical security offerings and extend its safety and security ecosystem.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 3:02 pm

AAPL

Apple Inc. is set to halt sales of the Apple Watch Series 9 and Ultra 2 in the U.S. due to an ITC import ban effective after December 21st, stemming from a patent dispute with Masimo over the SpO2 sensor. The ban is under presidential review, with a decision due by December 25th. Apple disagrees with the order and is exploring legal and technical options to keep the products available to U.S. customers.

Portfolio Pulse from Happy Mohamed

December 18, 2023 | 2:56 pm

AVIR

Atea Pharmaceuticals Inc. has been granted Orphan Drug Designation by the U.S. FDA for its oral prodrug aimed at treating dengue virus. This designation is given to drugs that treat rare diseases, providing benefits like tax credits and market exclusivity.

Portfolio Pulse from Happy Mohamed

December 18, 2023 | 2:49 pm

CKPT

Checkpoint Therapeutics Inc (CKPT) stock plummeted by 52.7% after receiving a complete response letter (CRL) from the FDA, which highlighted issues with a third-party manufacturer's inspection for their skin cancer treatment, cosibelimab. The CRL did not raise concerns about the treatment's effectiveness or safety. Checkpoint is optimistic about addressing the FDA's concerns and plans to launch cosibelimab in 2024.

Portfolio Pulse from Henry Khederian

December 18, 2023 | 2:48 pm

FCEL

XOM

FuelCell Energy Inc (NASDAQ:FCEL) stock is trading higher after announcing a pilot plant development with ExxonMobil Corp (NYSE:XOM) affiliate Esso Nederland BV at Rotterdam. The plant will test fuel cell technology to reduce CO2 emissions, with partial funding from the EU and the Netherlands Enterprise Agency. FuelCell Energy's CEO believes this technology is a game-changer for decarbonizing heavy industry.

Portfolio Pulse from Adam Eckert

December 18, 2023 | 2:45 pm

NVAX

Novavax Inc (NASDAQ:NVAX) announced that its updated Covid-19 vaccine, Nuvaxovid XBB.1.5, received emergency use authorization in Taiwan. The Taiwan FDA approved the vaccine for individuals 12 years and older, based on non-clinical data showing functional immune responses to several variants. Novavax will supply the vaccine under an existing agreement, with availability expected at vaccination centers across Taiwan. Despite the news, NVAX shares were down 1.30% at $5.33.

Portfolio Pulse from Adam Eckert

December 18, 2023 | 2:43 pm

RARE

Andelyn Biosciences has been chosen by Ultragenyx (NASDAQ:RARE) to perform late-stage PPQ manufacturing of UX111, a gene therapy for Sanfilippo Syndrome. UX111 has received multiple designations in the U.S. and EU, and Andelyn has already manufactured GMP supply for patient dosing. The PPQ batches are for future regulatory filings, and the partnership aims to expedite treatment for MPS IIIA patients.

Portfolio Pulse from Happy Mohamed

December 18, 2023 | 2:38 pm

EPOW

Sunrise New Energy Co., Ltd. (NASDAQ:EPOW) announced that their patent application for a 'Multivariable Particle Size Control System for Graphite Micropowder Production' has been accepted by the National Intellectual Property Bureau. The system improves upon traditional air grinding systems used in graphite manufacturing, offering adjustable variables and low failure rates. The company, which now holds 56 patents, reinforces its position as a leader in graphite manufacturing and advanced lithium-ion battery materials technology.

Portfolio Pulse from Happy Mohamed

December 18, 2023 | 2:34 pm